ELDN - Eledon Pharmaceuticals Inc. Qarzning balans kapitallashuviga nisbati
Eledon Pharmaceuticals (ELDN) transplantatsiya sohasida innovatsiyalarni joriy qilmoqda va patentlar orqali global yetakchilikka erishish salohiyatiga ega, biroq sotuvlarning yo'qligi va investitsiyalarga bog'liqlik pul oqimini beqaror qiladi hamda ushbu ko'rsatkich 0.01 darajasida turibdi. Ushbu narxlar grafigi aktivning dinamikasini aniq tarzda vizuallashtiradi. Biznesning ekologik profili laboratoriya kimyoviy nazorati va hujjatlarning raqamlashtirilishi bilan cheklangan.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ELDN_-_Eledon-Pharmaceuticals_-_Debt-to-Net-Assets-Ratio "Eledon Pharmaceuticals - ELDN Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Eledon Pharmaceuticals Inc. (ELDN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Eledon Pharmaceuticals|ELDN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Eledon|ELDN - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Eledon Pharmaceuticals, Inc|ELDN - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Eledon Pharmaceuticals
Kompaniyaning jamlanma tahliliyoti:Eledon Pharmaceuticals (ELDN)
Uzoq muddatli investor uchun Eledon Pharmaceuticals (ELDN) mahsulot siklining makroiqtisodiy tebranishlardan mustaqilligi tufayli ishonchli defensiv aktiv bo'lib ko'rinadi. Ushbu ko'rsatkich moliyaviy avtonomiyani baholash uchun umumiy majburiyatlarni kapitalning balans qiymati bilan solishtiradi, tarixiy qarzning kapitalizatsiyaga nisbati esa biznesning barqarorligini tasdiqlaydi, bunda defolt xatarlarining yo'qligi va leverajdan samarali foydalanish o'rtasidagi muvozanat rentabellikni optimallashtiradi.
Eledon Pharmaceuticals kimlar bilan raqobatlashadi
Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. PHAR|Qarzning balans qiymatiga nisbati nektar.com (NKTR)|UPB: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Zenas Bio ZBIO|IMNM (Immunome Corp) - Balans kapitallashuviga qarzlar|GOSS: Balans qiymatiga qarzlar|KalVista Pharmaceuticals (KALV) - Qarzning balans kapitallashuviga nisbati|septerna.com (SEPN) - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar PVLA (Pieris Pharmaceuticals, Inc.)|Balans qiymatiga qarzlar Savara Inc|Balans kapitallashuviga qarzlar Rigel Pharmaceuticals Inc RIGL|Qarzning balans qiymatiga nisbati ANAB (AnaptysBio Inc.)|ATXS: Qarzning balans kapitallashuviga nisbati|engene.com - Balans qiymatiga qarzlar|RAPT Therapeutics, Inc. (RAPT) - Qarzning balans kapitallashuviga nisbati|Aerovate Therapeutics Inc (JBIO) - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati Aclaris ACRS|KYTX (Kyverna Therapeutics, Inc) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Tiziana Life Sciences TLSA|Qarzlarning balans kapitallashuviga nisbati cabalettabio.com|Ventyx Biosciences, Inc. (VTYX) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Theratechnologies, Inc. (THTX)|Balans kapitallashuviga qarzlar AVTX (Avalo Therapeutics Inc.)|Agenus, Inc - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Climb Bio Inc (CLYM)|ZURA: Qarzning sof aktivlarga nisbati|ATYR (aTyr Pharma) - Qarzning balans kapitallashuviga nisbati|Adagene Inc. (ADAG) - Qarzning balans qiymatiga nisbati|IMA (ImageneBio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Shattuck Therapeutics|Balans kapitallashuviga qarzlar EQ (Equillium, Inc.)|Qarzning balans qiymatiga nisbati connectbiopharm.com (CNTB)|IMUX: Balans kapitallashuviga qarzlar|ATRA - Balans qiymatiga qarzlar|InflaRx GmbH - Qarzning balans qiymatiga nisbati|X4 Pharmaceuticals, Inc (XFOR) - Balans kapitallashuviga qarzlar|ACET - Qarzning balans qiymatiga nisbati|Celularity (CELU) - Qarzning balans kapitaliga nisbati|INMB: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Barinthus Biotherapeutics PLC|Balans kapitallashuviga qarzlar KZR (Kezar Life Sciences, Inc)|Qarzning balans qiymatiga nisbati SAB Biotherapeutics Inc (SABS)|Balans kapitallashuviga qarzlar AKTX (Akari Therapeutics)|Enlivex Therapeutics Ltd - Balans kapitallashuviga qarzlar|QTTB - Qarzning balans kapitallashuviga nisbati|GOVX: Qarzning balans kapitallashuviga nisbati|Edesa - Qarzning balans kapitallashuviga nisbati|iBio Corporation (IBIO) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar CARM (Carisma Therapeutics Inc)|Balans qiymatiga qarzlar XTLB|Qarzning balans kapitallashuviga nisbati Bolt Biotherapeutics (BOLT)|Qarzning balans kapitallashuviga nisbati hcwbiologics.com (HCWB)|APVO - Balans kapitallashuviga qarzlar|AIM ImmunoTech, Inc. - Qarzning balans qiymatiga nisbati|Aditxt Corp (ADTX) - Qarzning balans kapitallashuviga nisbati|GRI: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati XORTX Therapeutics (XRTX)|Vyome Holdings Inc. (HIND) - Qarzlarning balans kapitallashuviga nisbati|REVB - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Indaptus Corp|Balans kapitallashuviga qarzlar SCNI|Balans kapitallashuviga qarzlar CALI (calcimedica.com)|Qarzning balans kapitallashuviga nisbati Affimed N.V.|Allakos Inc - Qarzning sof aktivlarga nisbati|HOOK: Qarzning balans kapitallashuviga nisbati|IGMS - Qarzning balans qiymatiga nisbati|ITOS: Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar oceanbiomedical.com|TCBP - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Third Harmonic Bio Inc.